PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS
Recruiting
N/A
Interventional Study
Lung Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 108 (estimated)
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Percutaneous CT guided biopsy is a well-established, standard sampling technique for suspected neoplastic lesions located in peripheral region in lung parenchyma. Inconclusive results on CT guided biopsy is substantially higher in large lung lesions which are prone to cause peripheral pneumonia, atelectasis and even regional necrosis, which are hard to be distinguished from tumor on CT images.
Fu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age above 18 years
* INR \< 1.2 and platelet counts \> 80,000/mm3
* CT thorax with lung lesion more than 10 mm.
* Accessible lesions for CT-guided biopsy.
Exclusion Criteria:
* Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by -…
Contacts
No contact information available.